The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

NCT07049094 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

218

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor Adult
Cerebrovascular Disease

Interventions

DRUG: scalp nerve block with 0.25% hydrochloride bupivacaine and 0.67% bupivacaine liposome solution
DRUG: scalp nerve block with 0.50% hydrochloride bupivacaine

Sponsor

Zhejiang University